Phase II Trial of Thalidomide in Refractory/Relapsed Diffuse Large B-Cell Lymphoma and Hodgkin's Disease

Summary

Patients who have relapsed or refractory large B-cell lymphoma are being asked to take part in this study. The purpose of this study is to find out what effects (good and bad) the drug thalidomide has on patients and the lymphoma.

Timeline

Start

2003-07

Primary completion

—

Completion

2006-06

Outcome

Outcome not reported

Stopped (Business): “Celgene unable to continue funds.”

Drugs

Indications